Drug recall · October 31, 2018
Cidofovir injection 375 mg/mL recall
Why: Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31
- Lots / codes
Lot #: VCIA083, Exp. JUN2020
- Quantity
- 2,789 Units
- Company
- Heritage Pharmaceuticals, Inc., East Brunswick, NJ
- Distribution
- Nationwide within the United States
- Initiated
- October 15, 2018 · Voluntary: Firm initiated
- Classified
- October 24, 2018
- Reported
- October 31, 2018
- Ended
- March 29, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cidofovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.